Examiner: ALFANO, ALAN

Tech Center 1600 • Art Units: 1641

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

§102 Novelty

83.3%

§103 Obviousness

16.7%

§112 Clarity

App #	Title	Status	Assignee
18448842	COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF	Non-Final OA	Cartesian Therapeutics, Inc.
17907116	AUTONOMOUS KNOB DOMAIN PEPTIDES	Non-Final OA	UCB BIOPHARMA SRL

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.